Teva Says EpiPen Suit Only Remedy For Colo. Takings

By Daniel Ducassi · December 7, 2023, 10:03 PM EST

Teva Pharmaceuticals USA has urged a Colorado federal judge to keep alive its lawsuit challenging the state's epinephrine auto-injector affordability program as an unconstitutional taking, arguing that the alternative of repeatedly...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

Teva Pharmaceuticals USA, Inc. v. Weiser et al

Case Number

Court

Colorado

Nature of Suit

Constitutionality of State Statutes

Date Filed

October 03, 2023

Recent Articles By Daniel

October 22, 2024
Judge Skeptical Amgen Can't Sue Over Colo. Drug Price Caps
October 02, 2024
Colo. Judge Sees No Injuries In Health Data Breach Class Suit
September 09, 2024
Colo. Justices To Weigh Excess MedMal Damage Calculations
September 03, 2024
Justices Deny Oklahoma's Bid To Block HHS Funding Cut
August 20, 2024
Amgen's Drug Price Suit An Issue For Legislature, Judge Told
August 07, 2024
Okla. Wants Justices To Step Into Title X Funding Cut Fight
July 31, 2024
10th Circ. Finds Plenty To Prove Colo. Doctor's COVID Fraud
May 31, 2024
Judge Doubts Okla. Can Stop Title X Cut Over Abortion Stance
April 23, 2024
Colo. Neural Privacy Law Has Attys Scratching Their Heads
April 08, 2024
High Court Creating DEI Headwinds, Colo. AG Says